Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.

Bowen SR, Saini J, Chapman TR, Miyaoka RS, Kinahan PE, Sandison GA, Wong T, Vesselle HJ, Nyflot MJ, Apisarnthanarax S.

Radiother Oncol. 2015 Apr 28. pii: S0167-8140(15)00198-X. doi: 10.1016/j.radonc.2015.04.011. [Epub ahead of print]

PMID:
25934165
2.

Nuclear medicine and the emergency department patient: an illustrative case-based approach.

Behnia F, Gross JA, Ragucci M, Monti S, Mancini M, Elman S, Vesselle H, Mannelli L.

Radiol Med. 2015 Jan;120(1):158-70. doi: 10.1007/s11547-014-0451-7. Epub 2014 Aug 13. Review.

PMID:
25115293
3.

Improved prediction of lobar perfusion contribution using technetium-99m-labeled macroaggregate of albumin single photon emission computed tomography/computed tomography with attenuation correction.

Toney LK, Wanner M, Miyaoka RS, Alessio AM, Wood DE, Vesselle H.

J Thorac Cardiovasc Surg. 2014 Nov;148(5):2345-52. doi: 10.1016/j.jtcvs.2014.04.036. Epub 2014 Apr 19.

PMID:
24882061
4.

Multiple-gated acquisition scan with normal left ventricular ejection fraction and LBBB.

Mannelli L, Caldwell JH, Elman S, Lewis DH, Do BW, Vesselle H.

Clin Nucl Med. 2014 Sep;39(9):e410-2. doi: 10.1097/RLU.0000000000000247.

PMID:
24152644
5.
6.

Polyploidy road to therapy-induced cellular senescence and escape.

Wang Q, Wu PC, Dong DZ, Ivanova I, Chu E, Zeliadt S, Vesselle H, Wu DY.

Int J Cancer. 2013 Apr 1;132(7):1505-15. doi: 10.1002/ijc.27810. Epub 2012 Nov 16.

PMID:
22945332
7.

A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings.

Zhang Y, Minoshima S, Vesselle H, Lewis DH.

Clin Nucl Med. 2012 Jul;37(7):e173-5. doi: 10.1097/RLU.0b013e31824c5f0e.

PMID:
22691528
8.

Kinetic Analysis of 18F-FLT PET in Lung Tumors.

Brockenbrough JS, Vesselle H.

J Nucl Med. 2012 Jan 31. [Epub ahead of print] No abstract available.

9.

Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.

Brockenbrough JS, Souquet T, Morihara JK, Stern JE, Hawes SE, Rasey JS, Leblond A, Wiens LW, Feng Q, Grierson J, Vesselle H.

J Nucl Med. 2011 Aug;52(8):1181-8. doi: 10.2967/jnumed.111.089482. Epub 2011 Jul 15.

10.

Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung.

Salskov A, Hawes SE, Stern JE, Feng Q, Jordan CD, Wiens L, Rasey J, Lu H, Kiviat NB, Vesselle H.

J Oncol. 2011;2011:950140. doi: 10.1155/2011/950140. Epub 2011 Mar 28.

11.

Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).

Grierson JR, Brockenbrough JS, Rasey JS, Wiens L, Vesselle H.

Nucleosides Nucleotides Nucleic Acids. 2010 Jan;29(1):49-54. doi: 10.1080/15257770903451603.

12.

DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Hawes SE, Stern JE, Feng Q, Wiens LW, Rasey JS, Lu H, Kiviat NB, Vesselle H.

Lung Cancer. 2010 Aug;69(2):172-9. doi: 10.1016/j.lungcan.2009.11.002. Epub 2009 Nov 28.

13.

Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Brockenbrough JS, Morihara JK, Hawes SE, Stern JE, Rasey JS, Wiens LW, Feng Q, Vesselle H.

J Histochem Cytochem. 2009 Nov;57(11):1087-97. doi: 10.1369/jhc.2009.952804. Epub 2009 Aug 3.

14.

Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.

Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallières E, Wood DE.

J Thorac Oncol. 2008 Sep;3(9):971-8. doi: 10.1097/JTO.0b013e31818307a7.

PMID:
18758298
15.

DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.

Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):645-54. doi: 10.1158/1055-9965.EPI-07-2518.

16.

FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.

Salskov A, Tammisetti VS, Grierson J, Vesselle H.

Semin Nucl Med. 2007 Nov;37(6):429-39. Review. Erratum in: Semin Nucl Med. 2008 Mar;38(2):148.

PMID:
17920350
17.

A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.

Brockenbrough JS, Rasey JS, Grierson JR, Wiens LW, Vesselle H.

Nucl Med Biol. 2007 Aug;34(6):619-23.

PMID:
17707801
19.

Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.

Grierson JR, Brockenbrough JS, Rasey JS, Wiens LW, Schwartz JL, Jordan R, Vesselle H.

Nucl Med Biol. 2007 Jul;34(5):471-8. Epub 2007 May 11.

PMID:
17591546
20.

Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.

Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, Bastian P, Salskov A, Vallières E, Wood DE.

Clin Cancer Res. 2007 Jun 1;13(11):3255-63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk